| Literature DB >> 22650177 |
Francois Bischoff1, Didier Berthelot, Michel De Cleyn, Gregor Macdonald, Garrett Minne, Daniel Oehlrich, Serge Pieters, Michel Surkyn, Andrés A Trabanco, Gary Tresadern, Sven Van Brandt, Ingrid Velter, Mirko Zaja, Herman Borghys, Chantal Masungi, Marc Mercken, Harrie J M Gijsen.
Abstract
The design and the synthesis of several chemical subclasses of imidazole containing γ-secretase modulators (GSMs) is described. Conformational restriction of pyridone 4 into bicyclic pyridone isosteres has led to compounds with high in vitro and in vivo potency. This has resulted in the identification of benzimidazole 44a as a GSM with low nanomolar potency in vitro. In mouse, rat, and dog, this compound displayed the typical γ-secretase modulatory profile by lowering Aβ42 and Aβ40 levels combined with an especially pronounced increase in Aβ38 and Aβ37 levels while leaving the total levels of amyloid peptides unchanged.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22650177 DOI: 10.1021/jm201710f
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446